Arovella Therapeutics Ltd

(ASX) ALA

Current PriceA$0.07

Market CapA$77.37M

Since IPO (2002)-98%

5 Year+0%

1 Year-34%

1 Month-3%

Arovella Therapeutics Ltd Financials at a Glance

Market Cap

A$77.37M

Revenue (TTM)

A$144.50K

Net Income (TTM)

-A$14.19M

EPS (TTM)

-A$0.01

P/E Ratio

-9.14

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Price

A$0.07

Volume

193,736

Open

A$0.06

Price

A$0.07

Volume

193,736

Open

A$0.06

Previous Close

A$0.07

Daily Range

A$0.06 - A$0.07

52-Week Range

A$0.06 - A$0.13

Estimated Earnings Date

Sep 2, 2026

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Price

A$0.07

Volume

193,736

Open

A$0.06

Previous Close

A$0.07

Daily Range

A$0.06 - A$0.07

52-Week Range

A$0.06 - A$0.13

Estimated Earnings Date

Sep 2, 2026

ALA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arovella Therapeutics Ltd

Industry

Pharmaceuticals

Sector

Health Care

CEO

Michael Baker, PhD, MBA

Website

www.arovella.com

Headquarters

Osborne Park, WA 6017, AU

ALA Financials

Key Financial Metrics (TTM)

Gross Margin

101.79%

Operating Margin

481.15%

Net Income Margin

239.95%

Return on Equity

-40.65%

Return on Capital

-55.80%

Return on Assets

-39.15%

Earnings Yield

-10.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$77.37M

Shares Outstanding

1.21B

Volume

193.74K

Avg. Volume

979.26K

Financials (TTM)

Gross Profit

A$85.35K

Operating Income

-A$20.73M

EBITDA

-A$29.20M

Operating Cash Flow

-A$12.91M

Capital Expenditure

-A$555.75K

Free Cash Flow

-A$13.47M

Cash & ST Invst.

A$19.37M

Total Debt

A$0.00

Arovella Therapeutics Ltd Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$59.15K

+96.0%

Gross Margin

0.00%

N/A

Market Cap

A$77.37M

N/A

Market Cap/Employee

A$2.87M

N/A

Employees

N/A

Net Income

-A$1.88M

+52.4%

EBITDA

-A$5.44M

+7.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$19.37M

+306.6%

Total Debt

A$0.00

N/A

Accounts Receivable

A$126.45K

+13.5%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-39.15%

N/A

Return on Invested Capital

-83.85%

N/A

Free Cash Flow

-A$1.76M

+34.4%

Operating Cash Flow

-A$1.71M

+35.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ATX.AXAmplia Therapeutics Limited

ATX.AXAmplia Therapeutics LimitedA$0.14-3.57%

BIO.AXBiome Australia Limited

BIO.AXBiome Australia LimitedA$0.25-2.88%

IMU.AXImugene Limited

IMU.AXImugene LimitedA$0.10-1.02%

RCE.AXRecce Pharmaceuticals Ltd

RCE.AXRecce Pharmaceuticals LtdA$0.39-1.28%

ILA.AXIsland Pharmaceuticals Limited

ILA.AXIsland Pharmaceuticals LimitedA$0.47-2.08%

ALC.AXAlcidion Group Limited

ALC.AXAlcidion Group LimitedA$0.10-1.03%

ATH.AXAlterity Therapeutics Limited

ATH.AXAlterity Therapeutics LimitedA$0.60-5.51%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NXTCNextCure

NXTCNextCure$6.85+2.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.84-0.03%

PATHUiPath

PATHUiPath$11.95+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.36+0.01%

ERICTelefonaktiebolaget Lm Ericsson (publ)

ERICTelefonaktiebolaget Lm Ericsson (publ)$10.14-0.13%

FFord Motor Company

FFord Motor Company$13.81-0.00%

NOKNokia

NOKNokia$11.51-0.02%

Questions About ALA

What is the current price of Arovella Therapeutics Ltd?

Arovella Therapeutics Ltd is trading at A$0.07 per share.

What is the 52-week range for Arovella Therapeutics Ltd?

Over the past 52 weeks, Arovella Therapeutics Ltd has traded between A$0.06 and A$0.13.

How much debt does Arovella Therapeutics Ltd have?

As of the most recent reporting period, Arovella Therapeutics Ltd reported total debt of A$0.00.

How much cash does Arovella Therapeutics Ltd have on hand?

Arovella Therapeutics Ltd reported A$20.88M in cash and cash equivalents in its most recent financial results.

What is Arovella Therapeutics Ltd’s dividend yield?

Arovella Therapeutics Ltd does not currently have a dividend yield.

Arovella Therapeutics Ltd

Arovella Therapeutics Ltd Financials at a Glance

ALA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Arovella Therapeutics Ltd

ALA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Arovella Therapeutics Ltd Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALA

What is the current price of Arovella Therapeutics Ltd?

What is the 52-week range for Arovella Therapeutics Ltd?

How much debt does Arovella Therapeutics Ltd have?

How much cash does Arovella Therapeutics Ltd have on hand?

What is Arovella Therapeutics Ltd’s dividend yield?

Premium Investing Services